Scott Santarella, president, CEO, Bonnie J. Addario Lung Cancer Foundation, discusses some exciting updates in the field of lung cancer.

Santarella says developments in the field of immunotherapy for patients with lung cancer are very exciting. These new developments could have utility in both the front-line and relapsed setting.More pharmaceutical and biotech companies are also getting involved in lung cancer therapies. Santarella says there is a turning of the tide for lung cancer treatment and options that has not been there for a long time.

For more information about the Bonnie J. Addario Lung Cancer Foundation, visit 

Videos

Scott Santarella, president, CEO, Bonnie J. Addario Lung Cancer Foundation, discusses some exciting updates in the field of lung cancer.


Scott Santarella

Articles

Scott Santarella Discusses Exciting Updates in the Field of Lung Cancer